Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625522.RAMOusdFGJqQBjqY-rr0KDE4L7kClloxtiHaX-f_Kn3jo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625522.RAMOusdFGJqQBjqY-rr0KDE4L7kClloxtiHaX-f_Kn3jo130_assertion type Assertion NP625522.RAMOusdFGJqQBjqY-rr0KDE4L7kClloxtiHaX-f_Kn3jo130_head.
- NP625522.RAMOusdFGJqQBjqY-rr0KDE4L7kClloxtiHaX-f_Kn3jo130_assertion description "[This work suggests that multilevel inhibition of the PI3K/Akt/mTOR pathway and double-block of cell cycle progression are effective strategies for DLBCL therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625522.RAMOusdFGJqQBjqY-rr0KDE4L7kClloxtiHaX-f_Kn3jo130_provenance.
- NP625522.RAMOusdFGJqQBjqY-rr0KDE4L7kClloxtiHaX-f_Kn3jo130_assertion evidence source_evidence_literature NP625522.RAMOusdFGJqQBjqY-rr0KDE4L7kClloxtiHaX-f_Kn3jo130_provenance.
- NP625522.RAMOusdFGJqQBjqY-rr0KDE4L7kClloxtiHaX-f_Kn3jo130_assertion SIO_000772 19223503 NP625522.RAMOusdFGJqQBjqY-rr0KDE4L7kClloxtiHaX-f_Kn3jo130_provenance.
- NP625522.RAMOusdFGJqQBjqY-rr0KDE4L7kClloxtiHaX-f_Kn3jo130_assertion wasDerivedFrom befree-20150227 NP625522.RAMOusdFGJqQBjqY-rr0KDE4L7kClloxtiHaX-f_Kn3jo130_provenance.
- NP625522.RAMOusdFGJqQBjqY-rr0KDE4L7kClloxtiHaX-f_Kn3jo130_assertion wasGeneratedBy ECO_0000203 NP625522.RAMOusdFGJqQBjqY-rr0KDE4L7kClloxtiHaX-f_Kn3jo130_provenance.